# Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

> clinical trial · VERIFIED · 2026-08-25

Status: RECRUITING · Sponsor: University of Washington · Condition: Muscle Invasive Bladder Carcinoma

- Company: University of Washington
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07579195

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.